Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Atacicept 75 mg	159
Overall Study	STARTED	Atacicept 150 mg	145
Overall Study	STARTED	Placebo	157
Overall Study	Treated	Atacicept 75 mg	157
Overall Study	Treated	Atacicept 150 mg	144
Overall Study	Treated	Placebo	154
Overall Study	COMPLETED	Atacicept 75 mg	112
Overall Study	COMPLETED	Atacicept 150 mg	62
Overall Study	COMPLETED	Placebo	111
Overall Study	NOT COMPLETED	Atacicept 75 mg	47
Overall Study	NOT COMPLETED	Atacicept 150 mg	83
Overall Study	NOT COMPLETED	Placebo	46

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00624338/flow